2-piperidone has been researched along with Cholangiocarcinoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jiang, HC; Liang, YJ; Liu, JR; Liu, LX; Pan, SH; Qu, LD; Song, RP; Sun, BS; Wang, JB; Yin, DL; Zheng, TS | 1 |
1 other study(ies) available for 2-piperidone and Cholangiocarcinoma
Article | Year |
---|---|
EF24 inhibits tumor growth and metastasis via suppressing NF-kappaB dependent pathways in human cholangiocarcinoma.
Topics: Apoptosis; Benzylidene Compounds; Cell Line, Tumor; Cell Movement; Cholangiocarcinoma; G2 Phase Cell Cycle Checkpoints; Humans; M Phase Cell Cycle Checkpoints; Neoplasm Metastasis; Neoplasm Proteins; NF-kappa B; Piperidones; Signal Transduction | 2016 |